<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="48446">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01716728</url>
  </required_header>
  <id_info>
    <org_study_id>2012P000418</org_study_id>
    <nct_id>NCT01716728</nct_id>
  </id_info>
  <brief_title>Identification of Undiagnosed Lysosomal Acid Lipase Deficiency</brief_title>
  <official_title>Identification of Undiagnosed Lysosomal Acid Lipase Deficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Synageva BioPharma Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Partners HealthCare maintains a Patient Data Registry (PDR) with information from all
      patient encounters at Partners HealthCare facilities. We intend to utilize the PDR to
      identify groups of patient who are of high clinical suspicion for undiagnosed lysosomal acid
      lipase deficiency. A group of potential participants will be identified through the PDR.
      Detailed records will be requested to further narrow to ideal participants based upon
      previously existing diagnoses and symptoms. Participants will be invited to partake in the
      study via a letter from their Partners care provider with supporting study details. Study
      participants will be evaluated in a one-time visit. A complete family and medical history
      will be collected. A physical exam will be performed, and up to 20cc of blood will be drawn.
      All participants will be notified of their disease status via letter and phone call from the
      study staff. If the study participant is diagnosed with LALD through this evaluation, proper
      follow-up recommendations and referrals will be provided. Our intent is to determine if
      existing patient data can successfully be utilized to aid in the identification of patients
      with rare genetic disease.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>August 2012</start_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>number of patients with previously undiagnosed GD identified  Time Frame:   up to 2 years  Description:     Safety Issue?:   No  number of patients with previously undiagnosed LALD identified</measure>
    <time_frame>up to 2 years</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Lysosomal Acid Lipase Deficiency</condition>
  <condition>Cholesterol Ester Storage Disease</condition>
  <arm_group>
    <arm_group_label>Enzyme analysis</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients invited for evaluation will undergo lysosomal acid lipase enzyme analysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>enzyme analysis</intervention_name>
    <arm_group_label>Enzyme analysis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Individuals must have records available in the Partners HealthCare Patient Data
             Registry

        Exclusion Criteria:

          -  Individuals must not have a diagnosis of Lysosomal Acid Lipase Deficiency
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katherine B Sims, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 10, 2013</lastchanged_date>
  <firstreceived_date>October 26, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Katherine Sims, MD</investigator_full_name>
    <investigator_title>Neurologist</investigator_title>
  </responsible_party>
  <keyword>Lysosomal Acid Lipase Deficiency</keyword>
  <keyword>Cholesterol Ester Storage Disease</keyword>
  <keyword>Wolman Disease</keyword>
  <keyword>Lysosomal Storage Disorder</keyword>
  <keyword>Metabolic Disease</keyword>
  <keyword>Recessive Inheritance</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cholesterol Ester Storage Disease</mesh_term>
    <mesh_term>Wolman Disease</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
